CRT Capital Starts Ultragenyx Pharma (RARE) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to CRT Capital Starts Ultragenyx Pharma (RARE) at Buy

Jefferies Weighs In on Ultragenyx Pharma (RARE) Related to SIMD Abstracts

March 25, 2015 7:34 AM EDT

Jefferies analyst Ryan Martins provided his take on SIMD abstracts relevant to Ultragenyx Pharma (NASDAQ: RARE). The firm reiterated a Buy rating and $74 price target.

Martins commented, "RARE will present 12 month data from the eIND patient on rhGUS, where we expect... More